ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,733.50
5.00 (0.29%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.29% 1,733.50 1,732.50 1,733.00 1,739.50 1,724.50 1,733.00 4,237,056 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.48 71.35B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,728.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,739.50p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £71.35 billion. Gsk has a price to earnings ratio (PE ratio) of 14.48.

Gsk Share Discussion Threads

Showing 21676 to 21700 of 33150 messages
Chat Pages: Latest  870  869  868  867  866  865  864  863  862  861  860  859  Older
DateSubjectAuthorDiscuss
29/7/2020
13:15
Companies would die for GSK two billion cash flow each quarter.
montyhedge
29/7/2020
13:14
I thought they said full year eps guidance still intact.See what directors say at 2pm.19p dividend in the bag.
montyhedge
29/7/2020
13:11
Miserable market reaction to not too bad results! Especially since the price has tumbled over the last week in anticipation of worse figures.
tradermichael
29/7/2020
12:59
Poor results. Another dividend magnet with zero growth and now the likelihood of dividend cut. Years of getting behind the curve re drug development now catching up with them. Will buy in when they get back to 13 quid.
porsche1945
29/7/2020
12:30
Results presentation

A webcast of the quarterly results presentation hosted by Emma Walmsley, GSK CEO, will be held at 2pm BST on 29 July 2020. Presentation materials will be published on www.gsk.com prior to the webcast and a transcript of the webcast will be published subsequently.

tradermichael
29/7/2020
12:30
Solid 5% dividend payer, cheque on the doormat every 13 weeks.
montyhedge
29/7/2020
12:29
MONSTER RALLLYYYYYYY imminent on this one below guys

DNL = 3x Approvals expected during next 2 months including an Orphan Drug with FDA decision on September 29 = CHEAPEST UK Biotech a potential 500%++ GEM

Diurnal Group (DNL) = MCap £42 M / Cash £15 M or enough untill early 2022 / LOTS of BIG milestones on the way = Still the MOST attractive and CHEAPEST pharma stock in UK has potential to run toward 200p very fast especially on approval of Alkindi in USA (expected in September) and Chronocort in Europe (expected in Q1 ) =STRONG BUY AGGRESSIVE a sleeping giant here .GL

Market Cap £42 million
Cash £15 million
Price 35p

Alkindi approval in Australia expected this Quarter
Alkindi approval in Israel expected this Quarter
FDA decision for Alkindi on September 29
EMA Decision for Chronocort expected in early Q1 2021

ih_752952
29/7/2020
12:25
I worked for Yellow Pages Sales Ltd in Surbiton way back in the day
and on missing a monthly sales target, attempted to 'explain' this to
my the manager - he said to me 'reasons, excuses, bullsh1t' -
I never missed another target!.

GSK - lots of reasons, lots of excuses (some valid in this case), I wont use the other word.

essentialinvestor
29/7/2020
12:17
Be adding more if drops to 1570
andyadvfn1
29/7/2020
12:13
Lol let's hope so, very much doubt it, investors looking for safe dividend paying companies. Not many about.
montyhedge
29/7/2020
12:12
Waiting for the right moment to buy, 5% yield I can live that in these markets.
montyhedge
29/7/2020
12:11
TEST OF £15 coming up
onehanded
29/7/2020
12:09
Nope, not gonna like them one little bit.
Hence buying opportunity?

thamestrader
29/7/2020
12:08
Market does not like the results then
watfordhornet
29/7/2020
12:07
Another 19p dividend in the bag, figures has forecast by CEO.
montyhedge
29/7/2020
09:26
Sanofi/GSK not being bias I think will be the winning vaccine. Sanofi great track record with influenza vaccines.
montyhedge
29/7/2020
08:52
"expects a Phase 1/2 study to start in September"

Still at incredibly early stages. If successful, well into 2021 and seems behind the crowd.

alphorn
29/7/2020
08:51
Sanofi, GSK Agree With UK Government to Supply Up to 60 Million Doses of Covid-19 VaccineSource: Dow Jones News By Ian Walker Sanofi S.A. and GlaxoSmithKline PLC said Wednesday that they have reached an agreement with the U.K. government to supply up to 60 million doses of a Covid-19 vaccine, subject to final contract.The French and U.K. pharmaceutical companies said the vaccine candidate is based on Sanofi's technology that produces an influenza vaccine as well as GSK's pandemic adjuvant technology.Sanofi is leading clinical development and registration of the Covid-19 vaccine and plans a Phase 1, 2 study in September, followed by a Phase 3 study by the end of the year. If data proves positive, regulatory approval could be received in the first half of next year, it said.spud
spud
29/7/2020
08:48
Of course they will set in stone, these quarterly dividends.
montyhedge
29/7/2020
08:39
How do you know that? They have not declared a dividend payment for 13 August - have to wait till after 12.00 noon today?
tradermichael
29/7/2020
08:31
Another 19p in the bag. Pharma's, software tech, gold, the only place to be in these markets.
montyhedge
29/7/2020
08:03
Yes I know.
montyhedge
29/7/2020
07:48
Monty: x div date will be 13 August .... ;0)
tradermichael
29/7/2020
07:25
Good news on the vaccine, promising potential.
our haven
28/7/2020
18:50
Markets expecting a 1% to 4% drop in revenue that's priced in at current shareprice.
montyhedge
Chat Pages: Latest  870  869  868  867  866  865  864  863  862  861  860  859  Older

Your Recent History

Delayed Upgrade Clock